<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wiki.tiffa.net/w/index.php?action=history&amp;feed=atom&amp;title=Acefurtiamine</id>
	<title>Acefurtiamine - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wiki.tiffa.net/w/index.php?action=history&amp;feed=atom&amp;title=Acefurtiamine"/>
	<link rel="alternate" type="text/html" href="https://wiki.tiffa.net/w/index.php?title=Acefurtiamine&amp;action=history"/>
	<updated>2026-07-07T06:02:59Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.0</generator>
	<entry>
		<id>https://wiki.tiffa.net/w/index.php?title=Acefurtiamine&amp;diff=133123&amp;oldid=prev</id>
		<title>Fire at 23:23, 2 April 2024</title>
		<link rel="alternate" type="text/html" href="https://wiki.tiffa.net/w/index.php?title=Acefurtiamine&amp;diff=133123&amp;oldid=prev"/>
		<updated>2024-04-02T23:23:22Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 08:23, 3 April 2024&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l47&quot;&gt;Line 47:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 47:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;!--T:3--&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;!--T:3--&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&#039;&#039;&#039;Acefurtiamine&#039;&#039;&#039; ([[International Nonproprietary Name|INN]]) is a [[Vitamin B1 analogue|vitamin B&amp;lt;sub&amp;gt;1&amp;lt;/sub&amp;gt; analog]] in a manner similar to the [[GABA]]ergic activity of the [[thiamine]] derivative [[clomethiazole]].&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;ref name=&quot;MartindaleSciences1993&quot;&amp;gt;{{cite book| vauthors = Martindale W |title=The Extra Pharmacopoeia|url=https://books.google.com/books?id=EGZWAAAAYAAJ |year=1993 |publisher= Pharmaceutical Press |isbn=978-0-85369-300-0 |page=1053}}&amp;lt;/ref&amp;gt; &lt;/del&gt; It functions as an [[analgesic]] agent at sufficient doses.&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;{{medcn|date=April 2016}}&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&#039;&#039;&#039;Acefurtiamine&#039;&#039;&#039; ([[International Nonproprietary Name|INN]]) is a [[Vitamin B1 analogue|vitamin B&amp;lt;sub&amp;gt;1&amp;lt;/sub&amp;gt; analog]] in a manner similar to the [[GABA]]ergic activity of the [[thiamine]] derivative [[clomethiazole]].  It functions as an [[analgesic]] agent at sufficient doses.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== Further reading == &amp;lt;!--T:4--&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== Further reading == &amp;lt;!--T:4--&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Fire</name></author>
	</entry>
	<entry>
		<id>https://wiki.tiffa.net/w/index.php?title=Acefurtiamine&amp;diff=133108&amp;oldid=prev</id>
		<title>Fire: Created page with &quot;&lt;languages /&gt; &lt;translate&gt; &lt;!--T:1--&gt; {{Short description|Chemical compound}} {{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 477237993 | IUPAC_name = (3&#039;&#039;E&#039;&#039;)-4-{[(4-Amino-2-methylpyrimidin-5-yl)methyl](formyl)amino}-3-[(furan-2-ylcarbonyl)sulfanyl]pent-3-en-1-yl (acetyloxy)acetate | image = Acefurtiamine.svg | width = | drug_name =  &lt;!--Clinical data--&gt; | tradename =   | licence_EU = &lt;!-- EMEA requires brand name --&gt; | licence_US = &lt;!--...&quot;</title>
		<link rel="alternate" type="text/html" href="https://wiki.tiffa.net/w/index.php?title=Acefurtiamine&amp;diff=133108&amp;oldid=prev"/>
		<updated>2024-04-02T23:17:05Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;&amp;lt;languages /&amp;gt; &amp;lt;translate&amp;gt; &amp;lt;!--T:1--&amp;gt; {{Short description|Chemical compound}} {{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 477237993 | IUPAC_name = (3&amp;#039;&amp;#039;E&amp;#039;&amp;#039;)-4-{[(4-Amino-2-methylpyrimidin-5-yl)methyl](formyl)amino}-3-[(furan-2-ylcarbonyl)sulfanyl]pent-3-en-1-yl (acetyloxy)acetate | image = Acefurtiamine.svg | width = | drug_name =  &amp;lt;!--Clinical data--&amp;gt; | tradename =   | licence_EU = &amp;lt;!-- EMEA requires brand name --&amp;gt; | licence_US = &amp;lt;!--...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;&amp;lt;languages /&amp;gt;&lt;br /&gt;
&amp;lt;translate&amp;gt;&lt;br /&gt;
&amp;lt;!--T:1--&amp;gt;&lt;br /&gt;
{{Short description|Chemical compound}}&lt;br /&gt;
{{Drugbox&lt;br /&gt;
| Verifiedfields = changed&lt;br /&gt;
| Watchedfields = changed&lt;br /&gt;
| verifiedrevid = 477237993&lt;br /&gt;
| IUPAC_name = (3&amp;#039;&amp;#039;E&amp;#039;&amp;#039;)-4-{[(4-Amino-2-methylpyrimidin-5-yl)methyl](formyl)amino}-3-[(furan-2-ylcarbonyl)sulfanyl]pent-3-en-1-yl (acetyloxy)acetate&lt;br /&gt;
| image = Acefurtiamine.svg&lt;br /&gt;
| width =&lt;br /&gt;
| drug_name = &lt;br /&gt;
&amp;lt;!--Clinical data--&amp;gt;&lt;br /&gt;
| tradename =  &lt;br /&gt;
| licence_EU = &amp;lt;!-- EMEA requires brand name --&amp;gt;&lt;br /&gt;
| licence_US = &amp;lt;!-- FDA may use generic name --&amp;gt;&lt;br /&gt;
| DailyMedID = &amp;lt;!-- preference to licence_US --&amp;gt;&lt;br /&gt;
| pregnancy_AU = &amp;lt;!-- A / B1 / B2 / B3 / C / D / X --&amp;gt;&lt;br /&gt;
| pregnancy_US = &amp;lt;!-- A / B            / C / D / X --&amp;gt;&lt;br /&gt;
| pregnancy_category =  &lt;br /&gt;
| legal_AU = &amp;lt;!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled--&amp;gt;&lt;br /&gt;
| legal_CA = &amp;lt;!-- Schedule I, II, III, IV, V, VI, VII, VIII --&amp;gt;&lt;br /&gt;
| legal_UK = &amp;lt;!-- GSL, P, POM, CD, or Class A, B, C --&amp;gt;&lt;br /&gt;
| legal_US = &amp;lt;!-- OTC / Rx-only / Schedule I, II, III, IV, V --&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--T:2--&amp;gt;&lt;br /&gt;
&amp;lt;!--Identifiers--&amp;gt;&lt;br /&gt;
| CAS_number_Ref = {{cascite|changed|??}}&lt;br /&gt;
| CAS_number = 10072-48-7&lt;br /&gt;
| PubChem = 3037171&lt;br /&gt;
| ATC_prefix = none&lt;br /&gt;
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}&lt;br /&gt;
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}&lt;br /&gt;
| ChemSpiderID = 2300987&lt;br /&gt;
| ChEMBL_Ref = {{ebicite|changed|EBI}}&lt;br /&gt;
| ChEMBL = 2104090&lt;br /&gt;
| UNII_Ref = {{fdacite|correct|FDA}}&lt;br /&gt;
| UNII = 6APJ3D1308&lt;br /&gt;
&amp;lt;!--Chemical data--&amp;gt;&lt;br /&gt;
| C=21 | H=24 | N=4 | O=7 | S=1&lt;br /&gt;
| SMILES = O=C(OCC(=O)OCCC(\SC(=O)c1occc1)=C(/N(C=O)Cc2cnc(nc2N)C)C)C&lt;br /&gt;
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}&lt;br /&gt;
| StdInChI = 1S/C21H24N4O7S/c1-13(25(12-26)10-16-9-23-14(2)24-20(16)22)18(33-21(29)17-5-4-7-30-17)6-8-31-19(28)11-32-15(3)27/h4-5,7,9,12H,6,8,10-11H2,1-3H3,(H2,22,23,24)/b18-13+&lt;br /&gt;
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}&lt;br /&gt;
| StdInChIKey = MYBUGVXNAHWTOL-QGOAFFKASA-N&lt;br /&gt;
}}&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--T:3--&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Acefurtiamine&amp;#039;&amp;#039;&amp;#039; ([[International Nonproprietary Name|INN]]) is a [[Vitamin B1 analogue|vitamin B&amp;lt;sub&amp;gt;1&amp;lt;/sub&amp;gt; analog]] in a manner similar to the [[GABA]]ergic activity of the [[thiamine]] derivative [[clomethiazole]].&amp;lt;ref name=&amp;quot;MartindaleSciences1993&amp;quot;&amp;gt;{{cite book| vauthors = Martindale W |title=The Extra Pharmacopoeia|url=https://books.google.com/books?id=EGZWAAAAYAAJ |year=1993 |publisher= Pharmaceutical Press |isbn=978-0-85369-300-0 |page=1053}}&amp;lt;/ref&amp;gt;  It functions as an [[analgesic]] agent at sufficient doses.{{medcn|date=April 2016}}&lt;br /&gt;
&lt;br /&gt;
== Further reading == &amp;lt;!--T:4--&amp;gt;&lt;br /&gt;
{{refbegin}}&lt;br /&gt;
*{{cite book| veditors = Elks J, Ganellin CR |title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&amp;amp;pg=PA2|date=1990|publisher=Springer|isbn=978-1-4757-2085-3|doi=10.1007/978-1-4757-2085-3|pages=2–}}&lt;br /&gt;
{{refend}}&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--T:5--&amp;gt;&lt;br /&gt;
{{Vitamins}}&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--T:6--&amp;gt;&lt;br /&gt;
{{二次利用|date=6 February 2024}}&lt;br /&gt;
[[Category:Analgesics]]&lt;br /&gt;
[[Category:Acetate esters]]&lt;br /&gt;
[[Category:2-Furyl compounds]]&lt;br /&gt;
[[Category:Thioesters]]&lt;br /&gt;
[[Category:Pyrimidines]]&lt;br /&gt;
[[Category:Thiamine]]&lt;br /&gt;
[[Category:Formamides]]&lt;br /&gt;
&amp;lt;/translate&amp;gt;&lt;/div&gt;</summary>
		<author><name>Fire</name></author>
	</entry>
</feed>